Attached files
| file | filename |
|---|---|
| 8-K - FORM 8-K - ALKALINE WATER Co INC | f8k031620.htm |
SCOTTSDALE, Arizona — March
16, 2020 — The Alkaline Water
Company Inc. (NASDAQ and TSXV: WTER) (the “Company”)
today announces, subject to regulatory approval, a non-brokered private placement financing (the “Financing”) of up to 10,000,000 units (each, a “Unit”) at a price of US$0.40 per Unit for gross proceeds of up to US$4,000,000. Each Unit consists of one share of common stock of the Company (each, a “Share”)
and one share purchase warrant (each, a “Warrant”). One Warrant entitles the holder thereof to purchase one additional Share of the Company at a price of
US$0.50 per Share for a period of three years from closing.
The proceeds of the Financing are expected to be used for general working capital. Insiders of the Company may participate in the Financing.
Finder’s fees may be payable in connection with the Financing in accordance with the policies of the TSX Venture Exchange.
None of the securities to be issued in connection with the Financing will be or have been registered under the United States Securities Act of 1933, as amended (the “1933 Act”), and none may
be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the 1933 Act. This press release is being issued pursuant to Rule 135c of the 1933 Act and shall not constitute an offer to
sell or a solicitation of an offer to buy, nor shall there be any sale of the securities, in any state where such offer, solicitation or sale would be unlawful.
The Alkaline Water Company Inc.
Richard A. Wright
President and CEO
800-923-1910
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
President and CEO
800-923-1910
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.